Invention Application
- Patent Title: TETRAHYDROBENZOFURODIAZEPINONE COMPOUND AND PHARMACEUTICAL USE THEREOF
-
Application No.: US17493528Application Date: 2021-10-04
-
Publication No.: US20220162220A1Publication Date: 2022-05-26
- Inventor: Masafumi Inoue , Yosuke Ogoshi , Takayuki Furukawa , Takuya Machida , Ikuo Mitani , Kazuhito Harada , Yuichi Nakagawa , Nobutaka YAMAOKA
- Applicant: Japan Tobacco Inc.
- Applicant Address: JP Tokyo
- Assignee: Japan Tobacco Inc.
- Current Assignee: Japan Tobacco Inc.
- Current Assignee Address: JP Tokyo
- Priority: JP2020-168596 20201005
- Main IPC: C07D491/048
- IPC: C07D491/048
Abstract:
The present invention provides a compound having a Pim-1 inhibitory activity.
The present invention provides a compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same, and a pharmaceutical use thereof, and the like. wherein each symbol is as defined in the description.
The present invention provides a compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the same, and a pharmaceutical use thereof, and the like. wherein each symbol is as defined in the description.
Public/Granted literature
- US11643417B2 Tetrahydrobenzofurodiazepinone compound and pharmaceutical use thereof Public/Granted day:2023-05-09
Information query
